Literature DB >> 19101611

Conserved sequence in the aggrecan interglobular domain modulates cleavage by ADAMTS-4 and ADAMTS-5.

Hazuki E Miwa1, Thomas A Gerken, Tru D Huynh, Lori R Duesler, Meghan Cotter, Thomas M Hering.   

Abstract

BACKGROUND: Cleavage of aggrecan by ADAMTS proteinases at specific sites within highly conserved regions may be important to normal physiological enzyme functions, as well as pathological degradation.
METHODS: To examine ADAMTS selectivity, we assayed ADAMTS-4 and -5 cleavage of recombinant bovine aggrecan mutated at amino acids N-terminal or C-terminal to the interglobular domain cleavage site.
RESULTS: Mutations of conserved amino acids from P18 to P12 to increase hydrophilicity resulted in ADAMTS-4 cleavage inhibition. Mutation of Thr, but not Asn within the conserved N-glycosylation motif Asn-Ile-Thr from P6 to P4 enhanced cleavage. Mutation of conserved Thr residues from P22 to P17 to increase hydrophobicity enhanced ADAMTS-4 cleavage. A P4' Ser377Gln mutant inhibited cleavage by ADAMTS-4 and -5, while a neutral Ser377Ala mutant and species mimicking mutants Ser377Thr, Ser377Asn, and Arg375Leu were cleaved normally by ADAMTS-4. The Ser377Thr mutant, however, was resistant to cleavage by ADAMTS-5.
CONCLUSION: We have identified multiple conserved amino acids within regions N- and C-terminal to the site of scission that may influence enzyme-substrate recognition, and may interact with exosites on ADAMTS-4 and ADAMTS-5. GENERAL SIGNIFICANCE: Inhibition of the binding of ADAMTS-4 and ADAMTS-5 exosites to aggrecan should be explored as a therapeutic intervention for osteoarthritis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19101611      PMCID: PMC2656578          DOI: 10.1016/j.bbagen.2008.11.008

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  38 in total

1.  A conformational flexibility scale for amino acids in peptides.

Authors:  Fang Huang; Werner M Nau
Journal:  Angew Chem Int Ed Engl       Date:  2003-05-25       Impact factor: 15.336

2.  The intermediates of aggrecanase-dependent cleavage of aggrecan in rat chondrosarcoma cells treated with interleukin-1.

Authors:  J D Sandy; V Thompson; K Doege; C Verscharen
Journal:  Biochem J       Date:  2000-10-01       Impact factor: 3.857

3.  Activation of the proteolytic activity of ADAMTS4 (aggrecanase-1) by C-terminal truncation.

Authors:  Gui Gao; Jennifer Westling; Vivian P Thompson; Troy D Howell; Paul E Gottschall; John D Sandy
Journal:  J Biol Chem       Date:  2002-01-16       Impact factor: 5.157

4.  Distribution of aggrecanase (ADAMts 4/5) cleavage products in normal and osteoarthritic human articular cartilage: the influence of age, topography and zone of tissue.

Authors:  M T Bayliss; S Hutton; J Hayward; R A Maciewicz
Journal:  Osteoarthritis Cartilage       Date:  2001-08       Impact factor: 6.576

5.  Enzymes active in the areas undergoing cartilage resorption during the development of the secondary ossification center in the tibiae of rats ages 0-21 days: I. Two groups of proteinases cleave the core protein of aggrecan.

Authors:  E R Lee; L Lamplugh; M A Davoli; A Beauchemin; K Chan; J S Mort; C P Leblond
Journal:  Dev Dyn       Date:  2001-09       Impact factor: 3.780

6.  Truncation of the amino-terminus of the recombinant aggrecan rAgg1mut leads to reduced cleavage at the aggrecanase site. Efficient aggrecanase catabolism may depend on multiple substrate interactions.

Authors:  C Hörber; F H Büttner; C Kern; G Schmiedeknecht; E Bartnik
Journal:  Matrix Biol       Date:  2000-11       Impact factor: 11.583

7.  Sites of aggrecan cleavage by recombinant human aggrecanase-1 (ADAMTS-4).

Authors:  M D Tortorella; M Pratta; R Q Liu; J Austin; O H Ross; I Abbaszade; T Burn; E Arner
Journal:  J Biol Chem       Date:  2000-06-16       Impact factor: 5.157

8.  Mutations in the interglobular domain of aggrecan alter matrix metalloproteinase and aggrecanase cleavage patterns. Evidence that matrix metalloproteinase cleavage interferes with aggrecanase activity.

Authors:  F A Mercuri; R A Maciewicz; J Tart; K Last; A J Fosang
Journal:  J Biol Chem       Date:  2000-10-20       Impact factor: 5.157

9.  Autocatalytic cleavage of ADAMTS-4 (Aggrecanase-1) reveals multiple glycosaminoglycan-binding sites.

Authors:  Carl R Flannery; Weilan Zeng; Chris Corcoran; Lisa A Collins-Racie; Priya S Chockalingam; Tracy Hebert; Stewart A Mackie; Thomas McDonagh; Tara K Crawford; Kathy N Tomkinson; Edward R LaVallie; Elisabeth A Morris
Journal:  J Biol Chem       Date:  2002-08-28       Impact factor: 5.157

10.  Functional differences of the catalytic and non-catalytic domains in human ADAMTS-4 and ADAMTS-5 in aggrecanolytic activity.

Authors:  Kazunari Fushimi; Linda Troeberg; Hiroyuki Nakamura; Ngee Han Lim; Hideaki Nagase
Journal:  J Biol Chem       Date:  2007-12-22       Impact factor: 5.157

View more
  4 in total

Review 1.  ADAMTS proteases: key roles in atherosclerosis?

Authors:  Rebecca C Salter; Tim G Ashlin; Alvin P L Kwan; Dipak P Ramji
Journal:  J Mol Med (Berl)       Date:  2010-07-22       Impact factor: 4.599

2.  Comparison of sensory neuron growth cone and filopodial responses to structurally diverse aggrecan variants, in vitro.

Authors:  Justin A Beller; Brandon Kulengowski; Edward M Kobraei; Gabrielle Curinga; Christopher M Calulot; Azita Bahrami; Thomas M Hering; Diane M Snow
Journal:  Exp Neurol       Date:  2013-03-01       Impact factor: 5.330

Review 3.  The perineuronal net component of the extracellular matrix in plasticity and epilepsy.

Authors:  Paulette A McRae; Brenda E Porter
Journal:  Neurochem Int       Date:  2012-08-29       Impact factor: 3.921

4.  Development of a fluorogenic ADAMTS-7 substrate.

Authors:  Salvatore Santamaria; Frederic Buemi; Elisa Nuti; Doretta Cuffaro; Elena De Vita; Tiziano Tuccinardi; Armando Rossello; Steven Howell; Shahid Mehmood; Ambrosius P Snijders; Rens de Groot
Journal:  J Enzyme Inhib Med Chem       Date:  2021-12       Impact factor: 5.051

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.